It is impossible to test accurately bacterial susceptibility to the trimethoprimsulfamethoxazole combination co-trimoxazole with a single combined susceptibility disk. However, a variety of factors still affect the result even when separate trimethoprim and sulfamethoxazole disks are used. Experiments with separate disks showed that the optimum conditions for testing the susceptibilities of enterobacteria to these drugs were to flood-seed an agar plate with an inoculum of 104 to 105 organisms per ml, take off the excess liquid, and place a disk of 1 .g of trimethoprim and another of 50 gg of sulfamethoxazole on the surface of the agar with their centers exactly 25 mm apart. This method not only allowed the determination of resistance but also distinguished synergy.
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The agar diffusion technique is the method most commonly used to detect bacterial susceptibility to the antibacterial combination co-trimoxazole. Most laboratories determine bacterial susceptibility to the two component drugs of the combination, trimethoprim and sulfamethoxazole, by using a single disk. This disk usually contains 1 part trimethoprim and 20 parts sulfamethoxazole. However, the use of one disk for the susceptibility testing of two drugs is contrary to the guidelines of the Expert Committee on Antibiotics of the World Health Organization (10) . This committee proposed that two drugs should never be tested with a single disk, because it is impossible to determine the resistance patterns to the individual drugs.
Trimethoprim, until recently, has always been marketed in conjunction with sulfamethoxazole in order to exploit the synergy between the two drugs (7 4. Methods. Minimum inhibitory concentrations were determined as previously described (1) . The fractional inhibitory concentrations were measured for each strain by determining the minimum inhibitory concentrations of both trimethoprim and sulfamethoxazole, each in the presence of sublimiting concentrations of the other end with the result expressed as a fraction of the MIC found in the absence of the other drug (9) . The fractional inhibitory concentrations were plotted as an isobologram, and at the point of maximum potentiation the fractional inhibitory concentrations of both drugs were noted. The sum of these fractional inhibitory concentrations was taken as the fractional inhibitory index (6) , and a value of less than 0.7 was taken as significant for showing synergy (13 coli 114 (Ri). Similarly, although E. coli 114(R483) and E. coli 114(R751) showed identical resistance patterns, only with the latter could synergy be shown. E. coli R was resistant to both drugs, but synergy could be demonstrated.
When the six groups were tested for susceptibility to a single disk of 1 ,g of trimethoprim and 50 ig of sulfamethoxazole, each showed a zone of inhibition around the disk greater than 10 mm in diameter. When the two drugs were tested in separate disks at the same concentrations, each group gave a different response to the two drugs ( Fig. 1) . The synergy between the two drugs could easily be seen with E. coli 114 (Fig. 1, 1) , with bridging of the two inhibition (5, 17) . The synergy between the drugs was visible with E. coli 114(R1) (Fig. 1, 3 ) and E. coli 114(R751) (Fig. 1, 5) , by an extension of the zone around the "susceptible" disk towards the "resistant" disk in each case. With E. coli R, a zone of inhibition between the disks indicated synergy even though the strain was resistant to the individual disks. The demonstration of bacterial susceptibility and the synergy between the drugs was affected by a number of parameters.
Content of the sulfamethoxazole disk. The optimum ratio for synergy with the most organisms is 1 part trimethoprim to 20 parts sulfamethoxazole (5). This is an absolute ratio related to the minimum inhibitory concentrations of both drugs. However, most complex laboratory media antagonize the action of sulfonamides to a greater extent than they do that of trimethoprim (1, 2) and therefore reduce the effective sulfamethoxazole concentration (2) . Therefore, susceptibiity tests were performed with single disks containing 1 gg of trimethoprim in conjunction with others containing increasing concentrations of sulfamethoxazole.
The results for E. coli 114 and E. coli 114(R1) (Fig. 2) showed that synergy could be demonstrated with susceptible E. coli 114 when the sulfamethoxazole disk contained 20 gg of the drug. However, synergy was less obvious when a disk of this content was used with sulfame- 15 and 40 mm apart.
The results (Fig. 3) showed that with susceptible E. coli 114, the spacing of the disks was crucial.
At 15 Choice of laboratory media. The choice of suitable laboratory media for the susceptibility testing of both sulfonamides and trimethoprim is most important (4, 14) . Each strain was treated against one disk of trimethoprim (1 gg) and one of sulfamethoxazole (50 ,ug), spaced at 25 mm, on nine different laboratory media.
The results with susceptible E. coli 114 (Fig.  4) Inoeulum of bacteria. The susceptibiity of bacteria to both trimethoprim and sulfamethoxazole is dependent on the inoculum used (4) . An overnight broth culture of E. coli 114 was diluted in 10-fold steps, and each dilution was used as an inoculum to flood the surface of a Wellcotest Sensitivity Test Agar plate. A 1-ug trimethoprim disk and a 50-ig sulfamethoxazole disk were placed 25 mm apart on the agar surface. At a dilution of less than 1/100 there was no demonstration of synergy or sulfamethoxazole susceptibiity, even with the washed culture that had been centrifuged and resuspended in Davis-Mingioli medium (Fig. 5) Telfer Brunton, unpublished data). Treatment of these bacteria with the combination of the two drugs is, effectively, treatment with trimethoprim alone. The majority of the side effects of the combination arise from the sulfonamide component (15) , and, in the case of these resistant bacteria, therapy with trimethoprim alone would be preferable to administration of a drug that may do more harm than good. In susceptible bacteria and in some that are resistant to one component, synergy may be important. In these cases administration of combined therapy, based on a full susceptibility test result, may be used to deal with the infection.
One group of bacteria is resistant to both drugs individually but appears sensitive to the combined disk because of the synergy between the drugs. In this case, the clinician should be certain that the optimum ratio for synergy will be present at the site of action before prescribing combined therapy. LITERATURE CMD
